Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00078637
Status:
COMPLETED
Last Update Posted:
2014-12-23
First Post:
2004-03-03
Brief Title:
Dosing and Safety Study of E7820 in Patients With a Malignant Solid Tumor or Lymphoma
Sponsor:
Eisai Inc
Organization:
Eisai Inc
Study Overview
Official Title:
Phase I and Pharmacokinetic Study of E7820 After Oral Administration to Patients With Malignancy
Status:
COMPLETED
Status Verified Date:
2014-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a first-in-man open-label non-randomized multiple dose multiple cycle dose escalation study to determine the MTD safety PK and pharmacodynamics of E7820 in patients with a malignant solid tumor or lymphoma
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None